Scott Solomon, MD
Northside Hospital/BMTGA · BMTGA/Northside Hospital · BMTGA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Scott Solomon, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06337331 · Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell TransplantNorthside Hospital, Inc. · withdrawn · Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph2NCT06046248 · Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-DiseaseNorthside Hospital, Inc. · suspended · Chronic Graft Versus Host Disease · principal investigator
- N/ANCT05417971 · Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical TransplantationNorthside Hospital, Inc. · recruiting · Hematologic Malignancy · principal investigator
- N/ANCT04790344 · LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.Boston Scientific Corporation · completed · Heart Failure · principal investigator
- Ph4NCT04505774 · Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTEMatthew Neal MD · completed · Covid19 · principal investigator
- Ph2NCT02771197 · Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for TransplantNorthside Hospital, Inc. · completed · Acute Myeloid Leukemia · principal investigator
- N/ANCT02060344 · Hispanic Community Health Study / Study of LatinosNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Cardiovascular Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating CenterOT2HL156812 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI Lisa Newman, CRAIG REIST · fiscal years 2020 to 2024Named on NCT04505774
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.